Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics.

South San Francisco, CA
Joined June 2014
Today, we announced that the first patient has been dosed in the Phase 1 trial of STRO-006, our potential best-in-class ITGB6-targeting antibody-drug conjugate (ADC). Read more: ir.sutrobio.com/press-releas… $STRO #SutroBio
70
We're looking forward to the 17th Annual @World_ADC Conference, October 12–15, 2026, in San Diego. See the full lineup below, and learn more here: ir.sutrobio.com/press-releas… #WorldADC #SutroBio $STRO
🤖 Made with AI
1
1
161
We’re heading to NYC next week for the @Barclays Biotech 1x1 Day on October 6. If you’ll be attending and would like to connect, please reach out to schedule a meeting. #SutroBio $STRO #Barclays
93
We’re pleased to welcome Lucas Donigian as Senior Vice President, Business Development. Welcome to the team, Lucas! Read the announcement: ir.sutrobio.com/press-releas…
1
82
Don’t miss it! Today at 11:00 a.m. ET, Jane Chung, Chief Executive Officer, will present at the @HCWCO 28th Annual Global Investment Conference. Join the webcast here: ir.sutrobio.com/events-prese… #SutroBio $STRO #HCWConference
3
267
Today, we reported our Q2 2026 financial results and provided an encouraging early update from the Phase 1 study of STRO-004. Read the full press release here: ir.sutrobio.com/press-releas… #SutroBio $STRO
235
Thank you for an insightful discussion at the 2026 BIO International Convention. Sutro's Chief Scientific Officer, Hans-Peter Gerber, Ph.D., joined fellow panelists to discuss the strengths, weaknesses, and opportunities across today's leading oncology therapeutic modalities.
1
99
Sutro Biopharma is pleased to share that Chief Scientific Officer, Hans-Peter Gerber, Ph.D., will be participating as a panelist at the 2026 BIO International Convention. We hope to see you there! #SutroBio #BIO2026 #DrivenbyPurpose $STRO
1
167
We’re excited to share that our CFO Greg Chow will participate in a panel discussion at the BIO International Convention 2026 this week in San Diego. #SutroBio #BIO2026 #DrivenbyPurpose $STRO
114
We’re excited to share that our Chief Scientific Officer, Hans-Peter Gerber, Ph.D., will be participating in a panel discussion at @Biocentury 3rd Grand Rounds U.S., taking place June 3–5, 2026 in Seattle, Washington. #SutroBio #BioCentury $STRO
1
122
We’re excited to join the life science community at the @Jefferies Global Healthcare Conference in NYC. Sutro's presentation, which takes place tomorrow, June 4th at 9:20 a.m. ET, and available via webcast, here: ir.sutrobio.com/events-prese… #JefferiesHealthcare #SutroBio $STRO
1
80
Don’t miss it! Today at 12:30 p.m. ET, members of the Sutro management team will participate in the virtual @TDSecurities Cowen's 7th Annual Oncology Innovation Summit. Join the webcast here: ir.sutrobio.com/events-prese… #SutroBio $STRO
69
Jane Chung, CEO sat down with @BiotechTV to walk through Sutro's growing ADC pipeline — single- and dual-payload programs, key partnerships, and the science behind our approach to cancer therapeutics. Thanks for the feature, BiotechTV! Watch the full video to learn more. $STRO
𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: @SutroBio is developing next generation antibody-drug conjugates, including dual payload ADCs. CEO Jane Chung walks us through their programs. $STRO Full video: biotechtv.com/post/sutro-bio…
2
239
Pleased to contribute to @BioCentury Inc.’s latest article on ADC innovation, featuring insights from our CSO Hans-Peter Gerber on next-gen linker technologies: biocentury.com/article/65922… #BioCentury #SutroBio $STRO
137
Today, we reported our Q1 2026 financial results and business highlights. The full press release can be found here: ir.sutrobio.com/press-releas… #SutroBio $STRO
112
We’re pleased to share updates from Sutro Biopharma at the American Association for Cancer Research (@AACR) Annual Meeting 2026. Thank you to the AACR community for the thoughtful discussions throughout the meeting. #AACR26 #SutroBio $STRO
1
246
We’re pleased to present promising preclinical data across our ADC pipeline at the @AACR Annual Meeting 2026. For more info, ir.sutrobio.com/press-releas… $STRO #SutroBio #AACR26
241
We’re pleased to be presenting at the upcoming @AACR Annual Meeting 2026 in San Diego next month, including an oral presentation and 5 posters. More info here: ir.sutrobio.com/press-releas… #AACR26 #SutroBio $STRO
206
Today, we reported our Q4 YE 2025 financial results and business highlights. The full press release can be found here: ir.sutrobio.com/press-releas… #SutroBio $STRO
106
Don't miss it! Today, the STRO management team will present at the @CitizensBank Life Sciences Conference. Tune in via webcast here: event.summitcast.com/view/Bu… $STRO #SutroBio
104